Nama Insights

UnitedHealth Group (UNH)

Healthcare · Healthcare Plans · NYSE

S&P 500
UnitedHealth Group (UNH) is a Healthcare company in the Healthcare Plans industry. It has a market capitalization of $296.12B, a trailing price-to-earnings ratio of 16.2 and a free-cash-flow yield of 5.3%. Over the most recent reported fiscal year, revenue grew 11.8% and free cash flow per share fell 20.8%. Nama's AI scorecard rates it Buy, 6.9 out of 10. On 12-month momentum it ranks in the rising band of its market.
AI scorecard
Buy · 6.9/10
Positive, at the low end of Buy. As of Nov 20, 2026.
Momentum
Rising · +33.9% over 12 months ex. last
Second-best fifth of its market on the past year's move.
Shariah screen
Shariah Compliant
Passes our debt, cash and income screen; not a scholar's ruling.
Off its high
-46.1%
How far the last close sits under the highest price of the past five years.
Market cap$296.12B
Trailing P/E16.2
Price / book3.0
Price / sales0.7
FCF yield5.3%
Dividend yield2.8%
Gross margin19.8%
Operating margin5.3%
Net margin3.5%
Revenue growth (YoY)+11.8%
Revenue growth (3-yr annual)+11.3%
EPS growth (YoY)-41.1%
FCF/share growth (YoY)-20.8%
Beta0.5
ExchangeNYSE
SectorHealthcare
IndustryHealthcare Plans

UNH earnings

Next report: Jan 12, 2027 (Q4 2026, EPS estimate $2.27). Beat the EPS estimate in 3 of 4 recent quarters.

QuarterReportedEPSEstimateSurpriseRevenue
Q3 2026 Oct 13, 2026 $4.69 $4.14 +13.3% $112.69B
Q2 2026 Jul 16, 2026 $6.38 $4.92 +29.7% $112.03B
Q1 2026 Apr 21, 2026 $7.23 $6.60 +9.6% $111.72B
Q4 2025 Jan 27, 2026 $2.11 $2.11 +0.0% $113.22B

UNH analyst price target

Median target $490.00 from 25 analysts, ranging $385.00 – $531.00.

Healthcare Plans peers

TickerCompanyMarket capP/E
CVS CVS Health $102.41B 9.6
ELV Elevance Health $84.30B 12.9
CI Cigna Group $71.95B 8.6
HUM Humana $45.64B 28.7
CNC Centene $32.47B 12.4
MOH Molina Healthcare $10.61B 101.7
OSCR Oscar Health $8.13B 10.8
PGNY Progyny $2.61B 17.3
Explore live UNH data on Nama Insights →

Recent Congressional trades

UnitedHealth Group trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member Chamber Trade Amount Disclosed
Kevin Hern House Sell $15,001 - $50,000 Oct 13, 2026
Maria Elvira Salazar House Sell $1,001 - $15,000 Oct 7, 2026
Kevin Hern House Sell $15,001 - $50,000 Sep 25, 2026
John Boozman Senate Buy $1,001 - $15,000 Aug 20, 2026
Richard Dean McCormick House Sell $1,001 - $15,000 Aug 14, 2026
Alan Armstrong Senate Buy $15,001 - $50,000 Jul 21, 2026
Dan Newhouse House Sell $1,001 - $15,000 Jul 17, 2026
John Boozman Senate Buy $1,001 - $15,000 Jul 13, 2026
Richard Dean McCormick House Sell $1,001 - $15,000 Jul 9, 2026
Maria Elvira Salazar House Sell $1,001 - $15,000 Jul 7, 2026
Maria Elvira Salazar House Buy $1,001 - $15,000 May 8, 2026
Gilbert Cisneros House Buy $1,001 - $15,000 May 8, 2026

UNH FAQ

Is UNH a buy?
Nama's AI scorecard currently rates UnitedHealth Group Buy (6.9 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is UNH's P/E ratio?
UnitedHealth Group trades at a trailing price-to-earnings ratio of 16.2.
When does UNH report earnings?
UnitedHealth Group's next scheduled report is on Jan 12, 2027. Analysts expect EPS of $2.27.
What is the UNH price target?
The median analyst price target from 25 analysts is $490.00, with a range of $385.00 – $531.00.
Is UNH Shariah compliant?
Nama's AAOIFI-style screen reads UnitedHealth Group as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.
Does UNH pay a dividend?
Yes — UnitedHealth Group's dividend yield is 2.8%.